ATM and central nervous system cancer: In a study on glioma-initiating cells comparing the effect of KU55933 with an abrogation of NHEJ by a DNA-dependent protein kinase inhibitor (DNA-PKi), the combination of ATM inhibition and RT prolonged the survival of tumor-bearing mice, suggesting that HR dominates the survival of these cells [75].